Karin R. Aubrey, Ph. D. - Publications

Affiliations: 
University of Sydney, Camperdown, New South Wales, Australia 

16 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Aubrey KR, Sheipouri D, Balle T, Vandenberg RJ, Otsu Y. Glutamate, AP5 and NMDA do not directly modulate glycine receptors. Molecular Pharmacology. PMID 33051383 DOI: 10.1124/molpharm.120.000127  1
2018 Aubrey KR, Supplisson S. Heterogeneous Signaling at GABA and Glycine Co-releasing Terminals. Frontiers in Synaptic Neuroscience. 10: 40. PMID 30524262 DOI: 10.3389/fnsyn.2018.00040  1
2013 Wang L, Tu P, Bonet L, Aubrey KR, Supplisson S. Cytosolic transmitter concentration regulates vesicle cycling at hippocampal GABAergic terminals. Neuron. 80: 143-58. PMID 24094108 DOI: 10.1016/j.neuron.2013.07.021  1
2008 Rousseau F, Aubrey KR, Supplisson S. The glycine transporter GlyT2 controls the dynamics of synaptic vesicle refilling in inhibitory spinal cord neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 9755-68. PMID 18815261 DOI: 10.1523/JNEUROSCI.0509-08.2008  1
2008 Yang Z, Aubrey KR, Alroy I, Harvey RJ, Vandenberg RJ, Lynch JW. Subunit-specific modulation of glycine receptors by cannabinoids and N-arachidonyl-glycine. Biochemical Pharmacology. 76: 1014-23. PMID 18755158 DOI: 10.1016/j.bcp.2008.07.037  1
2007 Aubrey KR, Rossi FM, Ruivo R, Alboni S, Bellenchi GC, Le Goff A, Gasnier B, Supplisson S. The transporters GlyT2 and VIAAT cooperate to determine the vesicular glycinergic phenotype. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 6273-81. PMID 17554001 DOI: 10.1523/JNEUROSCI.1024-07.2007  1
2006 Wiles AL, Pearlman RJ, Rosvall M, Aubrey KR, Vandenberg RJ. N-Arachidonyl-glycine inhibits the glycine transporter, GLYT2a. Journal of Neurochemistry. 99: 781-6. PMID 16899062 DOI: 10.1111/j.1471-4159.2006.04107.x  1
2006 Supplisson S, Rousseau F, Roux MJ, Rossi FM, Aubrey KR. Glycine transporters: Structural insights from biophysics, physiology and human disease Acta Biomedica De L'Ateneo Parmense. 77: 38-39.  1
2005 Aubrey KR, Vandenberg RJ, Clements JD. Dynamics of forward and reverse transport by the glial glycine transporter, glyt1b. Biophysical Journal. 89: 1657-68. PMID 15951392 DOI: 10.1529/biophysj.105.061572  1
2004 Vandenberg RJ, Ju P, Aubrey KR, Ryan RM, Mitrovic AD. Allosteric modulation of neurotransmitter transporters at excitatory synapses. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 23: 1-11. PMID 15324920 DOI: 10.1016/j.ejps.2004.05.006  1
2004 Ju P, Aubrey KR, Vandenberg RJ. Zn2+ inhibits glycine transport by glycine transporter subtype 1b. The Journal of Biological Chemistry. 279: 22983-91. PMID 15031290 DOI: 10.1074/jbc.M312484200  1
2003 Pearlman RJ, Aubrey KR, Vandenberg RJ. Arachidonic acid and anandamide have opposite modulatory actions at the glycine transporter, GLYT1a. Journal of Neurochemistry. 84: 592-601. PMID 12558979 DOI: 10.1046/j.1471-4159.2003.01549.x  1
2001 Vandenberg RJ, Aubrey KR. Glycine transport inhibitors as potential antipsychotic drugs. Expert Opinion On Therapeutic Targets. 5: 507-518. PMID 12540263 DOI: 10.1517/14728222.5.4.507  1
2001 Aubrey KR, Vandenberg RJ. N[3-(4'-fluorophenyl)-3-(4'-phenylphenoxy)propyl]sarcosine (NFPS) is a selective persistent inhibitor of glycine transport. British Journal of Pharmacology. 134: 1429-36. PMID 11724748 DOI: 10.1038/sj.bjp.0704381  1
2001 Vandenberg RJ, Aubrey KR. Central and peripheral nervous system: Glycine transport inhibitors as potential antipsychotic drugs Expert Opinion On Therapeutic Targets. 5: 507-518.  1
2000 Aubrey KR, Mitrovic AD, Vandenberg RJ. Molecular basis for proton regulation of glycine transport by glycine transporter subtype 1b. Molecular Pharmacology. 58: 129-35. PMID 10860934  1
Show low-probability matches.